RNA medicines company Arcturus Therapeutics Inc. (San Diego, Calif.) will merge with Alcobra Ltd. (NASDAQ:ADHD) in a stock deal expected to close this quarter. Alcobra shareholders will own about 40% of the combined company; Arcturus...

Beth Israel’s cancer center launched the Institute for RNA Medicine to identify non-coding RNA pathways and develop therapeutics targeting the pathways. The institute will use the cancer center’s “mouse hospital” in which mice are genetically...